In 2023, Venus Medtech Hangzhou completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).
However, Venus Medtech Hangzhou has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Scope 1 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.
In 2023, the total operational greenhouse gas (GHG) emissions of Venus Medtech Hangzhou amounted to 4,109.44 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Venus Medtech Hangzhou decreased by 7.19%, showing that the company has made progress in taking action to reduce the climate impact of its operations.
In 2023, the total Scope 1 emissions of Venus Medtech Hangzhou were 88.82 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).
Since 2020, Venus Medtech Hangzhou's Scope 1 emissions have increased by 22.73%, reflecting a rising long-term trend in Scope 1 emissions over time.
Compared to the previous year (2022), Venus Medtech Hangzhou's Scope 1 emissions increased by 26.51%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.
In 2023, Venus Medtech Hangzhou reported Scope 2 greenhouse gas (GHG) emissions of 4,020.62 tCOâ‚‚e without specifying the calculation method.
Since 2020, Venus Medtech Hangzhou's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have increased by 75.34%, reflecting a rising long-term trend in Scope 2 emissions over time.
Compared to the previous year (2022), Venus Medtech Hangzhou's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Venus Medtech Hangzhou 's emissions have plateaued with no significant change in its energy consumption footprint.
In 2023, Venus Medtech Hangzhou reported its Scope 2 emissions using an unspecified methodology.